CU23358B7 - Vacuna que comprende una proteína cemento de garrapata - Google Patents
Vacuna que comprende una proteína cemento de garrapataInfo
- Publication number
- CU23358B7 CU23358B7 CU20020238A CU20020238A CU23358B7 CU 23358 B7 CU23358 B7 CU 23358B7 CU 20020238 A CU20020238 A CU 20020238A CU 20020238 A CU20020238 A CU 20020238A CU 23358 B7 CU23358 B7 CU 23358B7
- Authority
- CU
- Cuba
- Prior art keywords
- vaccine
- garrapata
- cement protein
- ectoparasites
- cement proteins
- Prior art date
Links
- 239000004568 cement Substances 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 244000078703 ectoparasite Species 0.000 abstract 3
- 241000894006 Bacteria Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000009260 cross reactivity Effects 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 230000014599 transmission of virus Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Insects & Arthropods (AREA)
- Mycology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere al uso de proteínas cemento de garrapatas en la producción de vacunas para proteger animales contra la picadura de ectoparásitos que se alimentan de sangre y contra la transmisión de virus, bacterias y otros patógenos por tales ectoparásitos. Cuando se usan como componentes de vacunas, la proteína cemento de garrapata de la invención confiere amplia reactividad recíproca contra una variedad de especies de ectoparásitos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0010068.5A GB0010068D0 (en) | 2000-04-25 | 2000-04-25 | Vaccine composition |
| GBGB0028606.2A GB0028606D0 (en) | 2000-04-25 | 2000-11-23 | Vaccine composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU23358B7 true CU23358B7 (es) | 2009-03-16 |
Family
ID=9890483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20020238A CU23358B7 (es) | 2000-04-25 | 2002-04-25 | Vacuna que comprende una proteína cemento de garrapata |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP4925236B2 (es) |
| CN (1) | CN101406696A (es) |
| AT (1) | ATE551068T1 (es) |
| CU (1) | CU23358B7 (es) |
| GB (2) | GB0010068D0 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110540583B (zh) * | 2018-05-29 | 2022-07-15 | 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) | 镰形扇头蜱液泡分拣蛋白分子及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9723945D0 (en) * | 1997-11-12 | 1998-01-07 | Nat Environmental Research Cou | Tissue cement |
-
2000
- 2000-04-25 GB GBGB0010068.5A patent/GB0010068D0/en not_active Ceased
- 2000-11-23 GB GBGB0028606.2A patent/GB0028606D0/en not_active Ceased
-
2001
- 2001-04-25 CN CNA2008102142020A patent/CN101406696A/zh active Pending
- 2001-04-25 JP JP2001577978A patent/JP4925236B2/ja not_active Expired - Lifetime
- 2001-04-25 AT AT01923827T patent/ATE551068T1/de active
-
2002
- 2002-04-25 CU CU20020238A patent/CU23358B7/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB0028606D0 (en) | 2001-01-10 |
| GB0010068D0 (en) | 2000-06-14 |
| JP2003531177A (ja) | 2003-10-21 |
| CN101406696A (zh) | 2009-04-15 |
| ATE551068T1 (de) | 2012-04-15 |
| JP4925236B2 (ja) | 2012-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE451119T1 (de) | Untereinheit-impfstoff gegen das respiratorische synzytialvirus | |
| WO2004030608A3 (en) | Nanoemulsion vaccines | |
| EP1499191A4 (en) | REGULATED ATTENUATION OF LIVE VACCINES TO ENHANCE CROSS-PROTECTIVE IMMUNOGENICITY | |
| DK1326633T3 (da) | Sammensætning omfattende immunogene mikropartikler | |
| WO2006068663A3 (en) | Vaccine compositions for treating coronavirus infection | |
| NO20034244D0 (no) | Mikrobielt fôr for akvakultur og landbruk | |
| WO2009077577A3 (en) | Vaccine antigens from piscirickettsia salmonis | |
| BR0110278A (pt) | Composição de vacina, anticorpo ou anti-soro, métodos de produção de um anticorpo ou de um anti-soro e de imunização de um animal contra um ectoparasita que se alimenta de sangue, proteìna de cemento de carrapato, e, uso de uma proteìna de cemento de carrapato | |
| WO2005035558A3 (en) | Piscirickettsia salmonis antigens and use thereof | |
| DK1471936T3 (da) | HIV-Vaccine og fremgangsmåde til anvendelse | |
| ATE413888T1 (de) | Salmonella vakzine | |
| MXPA03006971A (es) | Tratamiento del virus de hepatitis b. | |
| WO2004043404A3 (en) | Process for designing inhibitors of influenza virus non-structural protein 1 | |
| ATE349520T1 (de) | Gewebezementproteine aus rhipicephalus appendiculatus | |
| CU23358B7 (es) | Vacuna que comprende una proteína cemento de garrapata | |
| EA200301151A1 (ru) | Вакцина против натуральной оспы | |
| NO20062469L (no) | Streptococcus phocae vaksine | |
| ATE487489T1 (de) | Rekombinante intrazellulärepathogen-immunogene zusammensetzungen und anwendungsverfahren | |
| DE60238554D1 (de) | Vakzine gegen infektionskrankheiten | |
| WO2004082596A3 (en) | Yersinia species compositions | |
| DK1074266T3 (da) | Levende svækkede bakterier til anvendelse i vaccine | |
| AU6761301A (en) | Adjuvant composition comprising fha protein or fragment of fha protein in free form | |
| CY1107374T1 (el) | Εμβολιο ιχθυος εναντι της piscirickettsia salmonis | |
| ATE495757T1 (de) | Attenuierte bakterielle lebendvakzine | |
| WO2004009764A3 (en) | Methods and compositions concerning altered yellow fever virus strains |